Literature DB >> 25964691

Ebola virus disease: what canadian hospital pharmacists need to know.

Tasha D Ramsey1, Jennifer M Tung2, Heather Balogh3, April J Chan4.   

Abstract

Entities:  

Year:  2015        PMID： 25964691      PMCID： PMC4414081          DOI： 10.4212/cjhp.v68i2.1445

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  4 in total

1.  Pharmacists' investigational drug services aid Ebola response.

Authors:  Kate Traynor
Journal:  Am J Health Syst Pharm       Date:  2014-12-01       Impact factor: 2.637

2.  Ebola virus disease: roles and considerations for pharmacists.

Authors:  Anthony J Guarascio; Andrew C Faust; Lyndsay Sheperd; Lauren A O'Donnell
Journal:  Ann Pharmacother       Date:  2014-11-26       Impact factor: 3.154

Review 3.  Potential and emerging treatment options for Ebola virus disease.

Authors:  Bryan M Bishop
Journal:  Ann Pharmacother       Date:  2014-11-20       Impact factor: 3.154

4.  The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry.

Authors:  Gerrit Gehring; Katrin Rohrmann; Nkacheh Atenchong; Eva Mittler; Stephan Becker; Franziska Dahlmann; Stefan Pöhlmann; Florian W R Vondran; Sascha David; Michael P Manns; Sandra Ciesek; Thomas von Hahn
Journal:  J Antimicrob Chemother       Date:  2014-04-07       Impact factor: 5.790
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.